Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters

被引:289
作者
Choudhuri, Supratim
Klaassen, Curtis D.
机构
[1] USDA, CFSAN, OFAS, DBGNR, College Pk, MD 20740 USA
[2] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA
关键词
P-glycoprotein; MDR; MRP; BCRP; expression; localization; SNP; function;
D O I
10.1080/10915810600746023
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ATP-binding cassette (ABC) transporters constitute a large family of membrane proteins, which transport a variety of compounds through the membrane against a concentration gradient at the cost of ATP hydrolysis. Substrates of the ABC transporters include lipids, bile acids, xenobiotics, and peptides for antigen presentation. As they transport exogenous and endogenous compounds, they reduce the body load of potentially harmful substances. One by-product of such protective function is that they also eliminate various useful drugs from the body, causing drug resistance. This review is a brief summary of the structure, function, and expression of the important drug resistance-conferring members belonging to three subfamilies of the human ABC family; these areABCB1(MDR1/P-glycoprotein of subfamily ABCB), subfamily ABCC (MRPs), and ABCG2 (BCRP of subfamily ABCG), which are expressed in various organs. In the text, the transporter symbol that carries the subfamily name (such as ABCB1, ABCC1, etc.) is used interchangeably with the corresponding original names, such as MDR1/P-glycoprotein, MRP1, etc., respectively. Both nomenclatures are maintained in the text because both are still used in the transporter literature. This helps readers relate various names that they encounter in the literature. It now appears that P-glycoprotein, MRP1, MRP2, and BCRP can explain the phenomenon of multidrug resistance in all cell lines analyzed thus far. Also discussed are the gene structure, regulation of expression, and various polymorphisms in these genes. Because genetic polymorphism is thought to underlie interindividual differences, including their response to drugs and other xenobiotics, the importance of polymorphism in these genes is also discussed.
引用
收藏
页码:231 / 259
页数:29
相关论文
共 50 条
[41]   The role of drug efflux and uptake transporters ABCB1 (P-gp), ABCG2 (BCRP) and OATP1A/1B and of CYP3A4 in the pharmacokinetics of the CDK inhibitor milciclib [J].
Martinez-Chavez, Alejandra ;
Broeders, Jelle ;
Lebre, Maria C. ;
Tibben, Matthijs T. ;
Rosing, Hilde ;
Beijnen, Jos H. ;
Schinkel, Alfred H. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 159
[42]   Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro [J].
Cihalova, Daniela ;
Ceckova, Martina ;
Kucera, Radim ;
Klimes, Jiri ;
Staud, Frantisek .
BIOCHEMICAL PHARMACOLOGY, 2015, 98 (03) :465-472
[43]   Association Between ABCG2, ABCB1, ABCC2 Efflux Transporter Single-Nucleotide Variants and Irinotecan Adverse Effects in Patients With Colorectal Cancer: A Real-Life Study [J].
Barnett-Griness, Ofra ;
Rennert, Gad ;
Lejbkowicz, Flavio ;
Pinchev, Mila ;
Saliba, Walid ;
Gronich, Naomi .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (03) :704-711
[44]   Single nucleotide polymorphisms in ABCC2 and ABCB1 genes and their clinical impact in physiology and drug response [J].
Wada, M .
CANCER LETTERS, 2006, 234 (01) :40-50
[45]   “Effect of the drug transporters ABCB1, ABCC2, and ABCG2 on the disposition and brain accumulation of the taxane analog BMS-275,183” [J].
Serena Marchetti ;
Dick Pluim ;
Jos H. Beijnen ;
Roberto Mazzanti ;
Olaf van Tellingen ;
Jan H. M. Schellens .
Investigational New Drugs, 2014, 32 :1083-1095
[46]   Abcc4 Together with Abcb1 and Abcg2 Form a Robust Cooperative Drug Efflux System That Restricts the Brain Entry of Camptothecin Analogues [J].
Lin, Fan ;
Marchetti, Serena ;
Pluim, Dick ;
Iusuf, Dilek ;
Mazzanti, Roberto ;
Schellens, Jan H. M. ;
Beijnen, Jos H. ;
van Tellingen, Olaf .
CLINICAL CANCER RESEARCH, 2013, 19 (08) :2084-2095
[47]   Effect of the drug transporters ABCG2, Abcg2, ABCB1 and ABCC2 on the disposition, brain accumulation and myelotoxicity of the aurora kinase B inhibitor barasertib and its more active form barasertib-hydroxy-QPA [J].
Marchetti, Serena ;
Pluim, Dick ;
van Eijndhoven, Monique ;
van Tellingen, Olaf ;
Mazzanti, Roberto ;
Beijnen, Jos H. ;
Schellens, Jan H. M. .
INVESTIGATIONAL NEW DRUGS, 2013, 31 (05) :1125-1135
[48]   Resistance to daunorubicin, imatinib, or nilotinib depends on expression levels of ABCB1 and ABCG2 in human leukemia cells [J].
Kosztyu, Petr ;
Bukvova, Romana ;
Dolezel, Petr ;
Mlejnek, Petr .
CHEMICO-BIOLOGICAL INTERACTIONS, 2014, 219 :203-210
[49]   Effect of the drug transporters ABCG2, Abcg2, ABCB1 and ABCC2 on the disposition, brain accumulation and myelotoxicity of the aurora kinase B inhibitor barasertib and its more active form barasertib-hydroxy-QPA [J].
Serena Marchetti ;
Dick Pluim ;
Monique van Eijndhoven ;
Olaf van Tellingen ;
Roberto Mazzanti ;
Jos H. Beijnen ;
Jan H. M. Schellens .
Investigational New Drugs, 2013, 31 :1125-1135
[50]   Association of Single Nucleotide Polymorphisms in STAT3, ABCB1, and ABCG2 with Stomatitis in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib: A Retrospective Analysis in Japanese Patients [J].
Watanabe, Aimi ;
Yamamoto, Kazuhiro ;
Ioroi, Takeshi ;
Hirata, Sachi ;
Harada, Kenichi ;
Miyake, Hideaki ;
Fujisawa, Masato ;
Nakagawa, Tsutomu ;
Yano, Ikuko ;
Hiraiab, Midori .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2017, 40 (04) :458-464